CTOs on the Move

Cavapharma

www.cavapharma.com

 
Cavapharma is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cavapharma.com
  • 458-3539 boul Saint-Charles
    Kirkland, QC CAN H9H 3C4
  • Phone: 514.409.2282

Executives

Name Title Contact Details

Similar Companies

Navitus

Navitus Health Solutions LLC is a full service, URAC-accredited pharmacy benefit management company. As a zero-spread, full pass-through pharmacy benefit manager (PBM), Navitus aligns performance with plan sponsors` benefit goals to deliver comprehensive clinical programs and costsaving strategies that lower drug trend and promote good member health. Navitus provides its flexible services to individuals and group plans, including state employees, retirees and their dependents, as well as employees or members of managed care organizations, self-funded employers, coalitions and labor organizations.

Boyd Industries Inc

Boyd Industries Inc is a Clearwater, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carefirst Blue Cross Blue Shield

Carefirst Blue Cross Blue Shield is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atrium Innovations

Atrium Innovations is recognized around the world as an innovative leader in the development, manufacturing, and commercialization of science-based nutritional health products.

RRD International, LLC

Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).